| 摘要 |
The invention is directed to compounds of Formula (I), described herein, as well as pharmaceutically acceptable salts thereof, which act as CRFantagonists and are useful in the treatment of disorders and diseases associated with CRFreceptors, including CNS- related disorders and diseases. |
